Phospho-NCF1 (S345) Antibody

What is NCF1 and what is the significance of its phosphorylation at Ser345?

NCF1 (Neutrophil Cytosol Factor 1), also known as p47phox, is a 47 kDa cytosolic component of the NADPH oxidase complex essential for superoxide production in neutrophils and other phagocytic cells. The phosphorylation of NCF1 at Ser345 represents a critical regulatory mechanism for NADPH oxidase activation . While NCF1 contains multiple phosphorylation sites, Ser345 is particularly significant as it serves as a docking site for the proline isomerase Pin1, which induces conformational changes in NCF1, facilitating further phosphorylation by various protein kinases . This site is particularly important in priming pathways, as it can be phosphorylated in response to inflammatory mediators before full NADPH oxidase activation .

How does phosphorylation at Ser345 differ from other NCF1 phosphorylation sites?

Phosphorylation of NCF1 occurs at multiple serine residues (including Ser304, Ser315, Ser320, and Ser328) during neutrophil activation, but Ser345 phosphorylation has distinct characteristics:

Unlike other sites that show dynamic phosphorylation patterns directly correlated with NADPH oxidase activation, Ser345 often shows baseline phosphorylation in resting neutrophils and only modest increases upon stimulation . This suggests that Ser345 phosphorylation may serve as a regulatory checkpoint rather than a direct activation trigger.

Which signaling pathways regulate NCF1 Ser345 phosphorylation?

Research indicates that NCF1 Ser345 phosphorylation is primarily regulated by the p38 MAPK pathway in response to various stimuli. For example, the chemorepellent SLIT2 has been shown to increase phosphorylation of Ser345 in neutrophils through activation of p38 MAPK . This was demonstrated by experiments where p38 MAPK inhibitors (SB203580 and p38 MAPK Inhibitor IV) blocked SLIT2-induced NCF1 phosphorylation and subsequent ROS production . Additionally, proinflammatory cytokines like TNF-α can induce Ser345 phosphorylation through similar mechanisms . Unlike other phosphorylation sites primarily regulated by Protein Kinase C (PKC), Ser345 appears to be more responsive to stress-activated and inflammatory signaling pathways, positioning it as a key integration point between inflammatory signals and oxidative responses in neutrophils.

What are the optimal applications for Phospho-NCF1 (S345) antibodies?

Phospho-NCF1 (S345) antibodies have been validated for multiple research applications, with varying effectiveness across techniques:

Western blotting remains the most reliable and widely used application for these antibodies, allowing researchers to quantify phosphorylation levels across different experimental conditions . When designing experiments, it's advisable to include appropriate controls such as phosphatase-treated samples to validate antibody specificity to the phosphorylated form of NCF1.

What are the best experimental protocols for detecting NCF1 Ser345 phosphorylation in neutrophils?

For optimal detection of NCF1 Ser345 phosphorylation in neutrophils, researchers should consider the following methodology:

• Cell stimulation:

  • For priming studies: TNF-α (20 ng/ml, 5-15 minutes)

  • For NADPH oxidase activation: fMLF (1 μM, 5-10 seconds for peak response) or PMA (100-200 ng/ml, 2-12 minutes)

• Cell lysis protocol:

  • Use modified Laemmli sample buffer for complete NCF1 solubilization

  • Sonicate samples and centrifuge at low speed to ensure complete protein extraction

• Western blot recommendations:

  • Load equal amounts of protein (typically 20-50 μg)

  • Include phosphatase-treated controls

  • Always probe for total NCF1 in addition to phospho-NCF1 to normalize results

  • Quantify by densitometry and calculate phospho-NCF1/total NCF1 ratio

This approach allows for reliable quantification of phosphorylation dynamics with minimal artifacts or false positives. The rapid phosphorylation kinetics of NCF1 in response to fMLF require precise timing during stimulation, while PMA stimulation allows for a more extended observation window .

How can I validate the specificity of Phospho-NCF1 (S345) antibody in my experiments?

To ensure specificity of Phospho-NCF1 (S345) antibody detection, implement these validation strategies:

• Blocking peptide competition assay:

  • Pre-incubate antibody with phospho-peptide used as immunogen

  • Compare signals between blocked and unblocked antibody samples

  • A specific antibody will show significant signal reduction with blocked samples

• Phosphatase treatment control:

  • Treat half of your sample with lambda phosphatase

  • Run treated and untreated samples side by side

  • Loss of signal in phosphatase-treated samples confirms phospho-specificity

• Stimulation-dependent phosphorylation:

  • Compare unstimulated cells with those treated with known inducers of Ser345 phosphorylation (TNF-α, SLIT2)

  • Confirm increased signal after stimulation

• Size verification:

  • Always confirm that detected bands match expected molecular weight (47 kDa)

  • Watch for non-specific bands at different molecular weights

These validation steps are essential, as commercially available phospho-specific antibodies may vary in specificity across experimental conditions .

How do the kinetics of NCF1 phosphorylation at different sites relate to NADPH oxidase activation?

Research on the kinetics of NCF1 phosphorylation reveals complex temporal relationships between different phosphorylation sites and NADPH oxidase activation:

The rapid and transient phosphorylation pattern induced by fMLF (peaking at 10 seconds) contrasts with the slower but more sustained phosphorylation induced by PMA . Notably, the kinetics of fMLF-induced phosphorylation precede those of NADPH oxidase activation, while PMA-induced phosphorylation parallels oxidase activation . This suggests different mechanisms of activation and potentially different functional outcomes depending on the stimulus. Ser345 phosphorylation shows distinct patterns from the other sites, with higher baseline phosphorylation and less dramatic changes upon stimulation, suggesting its role as a regulatory checkpoint rather than a direct trigger of activation .

What role does p67phox play in regulating NCF1 Ser345 phosphorylation?

Research has uncovered an unexpected relationship between p67phox and NCF1 phosphorylation. Studies of neutrophils from p67phox-deficient patients with Chronic Granulomatous Disease (CGD) revealed:

• Reduced phosphorylation of NCF1 on Ser304, Ser315, Ser320, and Ser328 in p67phox-deficient neutrophils

• Addition of recombinant p67phox enhanced NCF1 phosphorylation on these sites

• Combined addition of p67phox and p40phox further increased phosphorylation levels

This suggests that beyond its known role as a component of the NADPH oxidase complex, p67phox also serves as a regulatory protein that facilitates NCF1 phosphorylation . The mechanism may involve p67phox acting as a scaffold that positions NCF1 in proximity to relevant kinases, or it may directly affect NCF1 conformation to expose phosphorylation sites. This finding adds complexity to our understanding of NADPH oxidase regulation and suggests that defective phosphorylation may contribute to the impaired oxidase activity in CGD patients with p67phox deficiency.

How does the phosphorylation of NCF1 at Ser345 affect neutrophil responses to microbial pathogens?

Phosphorylation of NCF1 at Ser345 plays a crucial role in modulating neutrophil antimicrobial responses:

• Priming effect: Ser345 phosphorylation serves as a priming mechanism that enhances subsequent ROS production in response to microbial challenge. For instance, the chemorepellent SLIT2 increases phosphorylation of Ser345 in neutrophils, which bolsters antimicrobial responses against pathogens like Staphylococcus aureus .

• Signaling integration: This phosphorylation site integrates signals from inflammatory mediators and pathogens, allowing for context-dependent neutrophil responses. Inhibition of p38 MAPK, which phosphorylates Ser345, diminishes neutrophil ROS production and antimicrobial activity .

• Disease implications: Impaired NCF1 phosphorylation contributes to defective neutrophil responses in conditions like Chronic Granulomatous Disease. Studies of p67phox-deficient neutrophils show reduced NCF1 phosphorylation, linking phosphorylation defects to impaired antimicrobial capacity .

These findings highlight the importance of Ser345 phosphorylation as a regulatory mechanism that fine-tunes neutrophil responses to different microbial challenges, potentially serving as a therapeutic target for enhancing antimicrobial immunity or dampening excessive inflammation.

What are the optimal storage conditions for maintaining Phospho-NCF1 (S345) antibody activity?

To maintain optimal antibody performance, follow these evidence-based storage recommendations:

What positive controls are recommended for validating Phospho-NCF1 (S345) antibody specificity?

For proper validation of Phospho-NCF1 (S345) antibodies, the following positive controls have been successfully used in published research:

These controls have been documented to show reliable signals with commercially available Phospho-NCF1 (S345) antibodies . When using these controls, it's advisable to run parallel samples with blocking peptides to confirm specificity. For instance, Western blot analysis of lysates from HepG2 cells treated with TNF-α shows a clear band at 47 kDa that can be blocked with the phospho-peptide used as immunogen , providing definitive evidence of antibody specificity.

How can I minimize background when using Phospho-NCF1 (S345) antibody in immunostaining?

To achieve clean, specific staining with Phospho-NCF1 (S345) antibodies in immunohistochemistry or immunofluorescence applications, implement these research-validated measures:

• Optimization of antibody concentration:

  • For IHC: Start with 1:100 dilution and titrate as needed (recommended range: 1:50-1:300)

  • For IF: Use more dilute solutions (1:50-1:200) than for Western blotting

• Blocking protocol enhancement:

  • Extend blocking time to 1-2 hours at room temperature

  • Use 5-10% normal serum from the same species as the secondary antibody

  • Add 0.1-0.3% Triton X-100 for better penetration in fixed tissues

  • Consider adding 1% BSA to reduce non-specific binding

• Technical modifications:

  • Increase washing steps (5x5 minutes) between antibody incubations

  • For IHC, optimize antigen retrieval methods (citrate buffer pH 6.0 has shown good results)

  • Use tyramide signal amplification for weak signals rather than increasing primary antibody concentration

  • For fluorescence, include a Sudan Black B treatment step (0.1% in 70% ethanol) to reduce autofluorescence

These approaches have been shown to improve signal-to-noise ratio across multiple experimental settings. Particularly for brain tissue, which can show high background, extended washing steps and careful antibody titration are essential for successful staining .

How is NCF1 Ser345 phosphorylation implicated in chronic granulomatous disease (CGD)?

Research into Chronic Granulomatous Disease (CGD) has revealed important connections with NCF1 phosphorylation:

• Phosphorylation defects in CGD patients:

  • Neutrophils from p67phox-deficient CGD patients show significantly decreased phosphorylation of p47phox/NCF1, including at Ser345

  • This suggests that beyond the direct absence of NADPH oxidase components, impaired phosphorylation signaling further compromises oxidase function

• Mechanistic implications:

  • p67phox appears to facilitate NCF1 phosphorylation, functioning as both a structural component and regulatory protein

  • In CGD patients with p67phox deficiency, the absence of this protein leads to reduced NCF1 phosphorylation, contributing to defective oxidase assembly and activation

• Therapeutic considerations:

  • Targeting pathways that enhance NCF1 phosphorylation might partially compensate for genetic defects in CGD

  • Understanding the complete phosphorylation profile in CGD patients could identify new therapeutic targets

These findings suggest that phosphorylation defects represent an additional layer of dysfunction in CGD beyond the primary genetic mutations, potentially offering new avenues for therapeutic intervention .

What role does NCF1 Ser345 phosphorylation play in inflammatory conditions?

NCF1 Ser345 phosphorylation appears to serve as a critical regulatory switch in inflammatory processes:

• Priming mechanism:

  • Inflammatory cytokines like TNF-α induce partial phosphorylation of NCF1 primarily at Ser345

  • This phosphorylation serves as a priming event that enhances subsequent neutrophil responses to activating stimuli

  • Phosphorylated Ser345 creates a docking site for the proline isomerase Pin1, which facilitates conformational changes in NCF1 and enhances NADPH oxidase assembly

• Disease associations:

  • In rheumatoid arthritis models, NCF1 polymorphisms affecting phosphorylation capacity are linked to disease severity

  • Low NADPH oxidase capacity due to impaired NCF1 function increases severity of arthritis through dysregulated T cell activation

  • Conversely, excessive NCF1 Ser345 phosphorylation may contribute to tissue damage in acute inflammatory conditions

• Potential therapeutic target:

  • Modulating NCF1 Ser345 phosphorylation could provide a targeted approach to control neutrophil-mediated inflammation

  • Both enhancement (for antimicrobial immunity) and inhibition (for inflammatory diseases) strategies could be therapeutically relevant depending on the clinical context

These findings highlight the complex dual role of NCF1 phosphorylation in regulating the balance between beneficial antimicrobial responses and detrimental inflammatory tissue damage .